Here’s Why Eli Lilly & Co. Stock Gapped Lower

Eli Lilly & Co. (LLY) just plummeted to $134 and could be headed to $130 near-term.  All on news it ended a clinical trial of its antibody drug in hospitalized COVID patients after federal researchers said it produced no marked improvementEli Lilly & Co. (LLY) just plummeted to $134 and could be headed to $130 near-term.  All on news it ended a clinical trial of its antibody drug in hospitalized COVID patients after federal researchers said it produced no marked improvementEli Lilly & Co. (LLY) just plummeted to $134 and could be headed to $130 near-term.  All on news it ended a clinical trial of its antibody drug in hospitalized COVID patients after federal researchers said it produced no marked improvementEli Lilly & Co. (LLY) just plummeted to $134 and could be headed to $130 near-term.  All on news it ended a clinical trial of its antibody drug in hospitalized COVID patients after federal researchers said it produced no marked improvement

Here’s Why Microgrid Demand Will Only Increase

Microgrid stocks, like CleanSpark (CLSK) are gaining attention with heat and blackouts hitting California. For one, utilities are realizing they can’t guarantee energy supply to their customers, especially in vulnerable areas. Two, power outages are becoming commonplace with wildfires, storms, earthquakes, and other natural disasters across the U.S. Three, as the latest virus pandemic wreaks …Microgrid stocks, like CleanSpark (CLSK) are gaining attention with heat and blackouts hitting California. For one, utilities are realizing they can’t guarantee energy supply to their customers, especially in vulnerable areas. Two, power outages are becoming commonplace with wildfires, storms, earthquakes, and other natural disasters across the U.S. Three, as the latest virus pandemic wreaks …

With the Pandemic, Thermal Imaging Demand is Soaring

Without a pandemic vaccine in hand, companies, airports, schools, and hospitals are turning to temperature scanning technology, such as infrared thermal cameras, in an effort to help reduce the spread of the virus. “Thermal imaging and sensing technology will certainly be among the lines of defense against the virus, according to market research firm Yole …Without a pandemic vaccine in hand, companies, airports, schools, and hospitals are turning to temperature scanning technology, such as infrared thermal cameras, in an effort to help reduce the spread of the virus. “Thermal imaging and sensing technology will certainly be among the lines of defense against the virus, according to market research firm Yole …

The S&P 500 is a Strong Predictor of Election Results

Election results won’t be easy to predict in 2020. However, history says the incumbent has the advantage when the market rallies in the months leading up to the big day.  Going back to 1928, incumbent presidents have won 90% of elections when the S&P 500 is positive in the previous three months, as reported by …Election results won’t be easy to predict in 2020. However, history says the incumbent has the advantage when the market rallies in the months leading up to the big day.  Going back to 1928, incumbent presidents have won 90% of elections when the S&P 500 is positive in the previous three months, as reported by …

The Top Reasons Gold Prices Could Be Heading Higher

Analysts remain bullish on gold. UBS for example believes gold could run even further and remain high “for longer than expected” on global uncertainty, as noted by CNBC. The analyst added the firm raised its forecast for gold next year from $1,850 to $2,100.  “An environment of negative real interest rates and global uncertainties, such …Analysts remain bullish on gold. UBS for example believes gold could run even further and remain high “for longer than expected” on global uncertainty, as noted by CNBC. The analyst added the firm raised its forecast for gold next year from $1,850 to $2,100.  “An environment of negative real interest rates and global uncertainties, such …

New Tesla Deal Fuels Massive Rally in Lithium Stock

With increasing demand for lithium, the world could run into a massive supply crunch.  All on the heels of the electric vehicle boom.  In fact, EVs could dominate demand for lithium over the next 10 years, reports Reuters, accounting for more than 75% of the lithium’s consumption. According to Reuters, “the electric vehicle industry must …With increasing demand for lithium, the world could run into a massive supply crunch.  All on the heels of the electric vehicle boom.  In fact, EVs could dominate demand for lithium over the next 10 years, reports Reuters, accounting for more than 75% of the lithium’s consumption. According to Reuters, “the electric vehicle industry must …

The Top Reasons to Invest in the Electric Vehicle Boom

The mere mention of electric vehicles is enough to drive related stocks higher.  Just over the last few days, Spi Energy Co. Ltd. for example exploded from a low of 97 cents to a high of $46.67 on an announcement it was launching an electric vehicle business. Even shares of Piedmont Lithium Ltd. popped fromThe mere mention of electric vehicles is enough to drive related stocks higher.  Just over the last few days, Spi Energy Co. Ltd. for example exploded from a low of 97 cents to a high of $46.67 on an announcement it was launching an electric vehicle business. Even shares of Piedmont Lithium Ltd. popped from

Big Demand for Microgrids Creating $47.4 Billion Investment Opportunity

Demand for microgrids has been explosive.  With fires, storms, and other emergency situations, businesses and consumers are rushing to obtain a better source of energy. Home microgrid demand in California skyrocketed 1,000% over the last month, according to Microgrid Knowledge. All in response to the wildfires and power shutoffs. “Not only has demand increased;Demand for microgrids has been explosive.  With fires, storms, and other emergency situations, businesses and consumers are rushing to obtain a better source of energy. Home microgrid demand in California skyrocketed 1,000% over the last month, according to Microgrid Knowledge. All in response to the wildfires and power shutoffs. “Not only has demand increase.

Why do we use it?

It is a long established fact that a reader will be distracted by the readable content of a page when looking at its layout. The point of using Lorem Ipsum is that it has a more-or-less normal distribution of letters, as opposed to using ‘Content here, content here’, making it look like readable English. Many desktop publishing packages and web page editors now use Lorem Ipsum as their default model text, and a search for ‘lorem ipsum’ will uncover many web sites still in their infancy. Various versions have evolved over the years, sometimes by accident, sometimes on purpose (injected humour and the like).

Where does it come from?

Contrary to popular belief, Lorem Ipsum is not simply random text. It has roots in a piece of classical Latin literature from 45 BC, making it over 2000 years old. Richard McClintock, a Latin professor at Hampden-Sydney College in Virginia, looked up one of the more obscure Latin words, consectetur, from a Lorem Ipsum passage, and going through the cites of the word in classical literature, discovered the undoubtable source. Lorem Ipsum comes from sections 1.10.32 and 1.10.33 of “de Finibus Bonorum et Malorum” (The Extremes of Good and Evil) by Cicero, written in 45 BC. This book is a treatise on the theory of ethics, very popular during the Renaissance. The first line of Lorem Ipsum, “Lorem ipsum dolor sit amet..”, comes from a line in section 1.10.32.

The standard chunk of Lorem Ipsum used since the 1500s is reproduced below for those interested. Sections 1.10.32 and 1.10.33 from “de Finibus Bonorum et Malorum” by Cicero are also reproduced in their exact original form, accompanied by English versions from the 1914 translation by H. Rackham.

Here’s Why Eli Lilly & Co. Stock Gapped Lower

Eli Lilly & Co. (LLY) just plummeted to $134 and could be headed to $13near-term.  All on news it ended a clinical trial of its antibody drug in hospitalized COVID patients after federal researchers said it produced no marked improvement. “The study of the monoclonal antibody called bamlanivimab was initially paused by the company onEli Lilly & Co. (LLY) just plummeted to $134 and could be headed to $130 near-term.  All on news it ended a clinical trial of its antibody drug in hospitalized COVID patientafter federal researchers said it produced no marked improvement. “The study of the monoclonal antibody called bamlanivimab was initially paused by the company on